Oramed Pharmaceuticals (ORMP) Competitors

Oramed Pharmaceuticals (NASDAQ:ORMP) and Benitec Biopharma (NASDAQ:BNTC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Do insiders & institutionals hold more shares of ORMP or BNTC?

12.7% of Oramed Pharmaceuticals shares are held by institutional investors. Comparatively, 52.2% of Benitec Biopharma shares are held by institutional investors. 13.7% of Oramed Pharmaceuticals shares are held by insiders. Comparatively, 1.3% of Benitec Biopharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Do analysts recommend ORMP or BNTC?

Benitec Biopharma has a consensus target price of $23.83, suggesting a potential upside of 91.59%. Given Benitec Biopharma's stronger consensus rating and higher probable upside, analysts clearly believe Benitec Biopharma is more favorable than Oramed Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oramed Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Benitec Biopharma	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	2 Strong Buy rating(s)	3.20

Which has better earnings & valuation, ORMP or BNTC?

Oramed Pharmaceuticals has higher revenue and earnings than Benitec Biopharma. Benitec Biopharma is trading at a lower price-to-earnings ratio than Oramed Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oramed Pharmaceuticals	$1.34M	63.71	-$19.06M	-$0.44	-4.75
Benitec Biopharma	N/A	N/A	-$21.75M	-$1.51	-8.24

Which has more risk and volatility, ORMP or BNTC?

Oramed Pharmaceuticals has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Comparatively, Benitec Biopharma has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500.

Is ORMP or BNTC more profitable?

Oramed Pharmaceuticals' return on equity of -11.34% beat Benitec Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oramed Pharmaceuticals	N/A	-11.34%	-10.73%
Benitec Biopharma	N/A	-38.26%	-35.71%

Does the media refer more to ORMP or BNTC?

In the previous week, Benitec Biopharma had 1 more articles in the media than Oramed Pharmaceuticals. MarketBeat recorded 2 mentions for Benitec Biopharma and 1 mentions for Oramed Pharmaceuticals. Oramed Pharmaceuticals' average media sentiment score of 1.89 beat Benitec Biopharma's score of 0.47 indicating that Oramed Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Oramed Pharmaceuticals	Very Positive
Benitec Biopharma	Neutral

Summary

Oramed Pharmaceuticals beats Benitec Biopharma on 9 of the 15 factors compared between the two stocks.